Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 3268-3272, July 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arafah, B. M.
Right arrow Articles by Pearson, O. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arafah, B. M.
Right arrow Articles by Pearson, O. H.

Influence of Tamoxifen and Estradiol on the Growth of Human Breast Cancer Cells in Vitro1

Baha'Uddin M. Arafah, Patricia Griffin, Nahida H. Gordon and Olof H. Pearson

Departments of Medicine [B. M. A., P. G., O. H. P.] and Mathematics and Statistics [N. H. G.], Case Western Reserve University, Cleveland, Ohio 44106

Cells obtained from freshly resected human breast cancer were grown in vitro utilizing the soft agar technique. The effects of adding an antiestrogen (tamoxifen, TAM) and 17ß-estradiol alone or simultaneously on cell growth were assessed. The addition of TAM (10-6 M) to the medium resulted in a significant decrease in cell growth in 26 of 36 (72%) estrogen receptor (ER)-positive tumors and in one of 5 ER-negative tumors (20%). The degree of inhibition caused by TAM was significantly higher in the ER-positive tumors that also contain the progesterone receptor (PgR) as compared to those that lacked that receptor (i.e., PgR negative) (46.2 ± 2% versus 36.2 ± 1.2% inhibition, P < 0.01). The simultaneous addition of 17ß-estradiol (10-8 M) neutralized the inhibitory effect of TAM (10-6 M) in the majority of tumors. With the presence of serum in the medium, the addition of 17ß-estradiol alone resulted in an enhancement of cell growth in 6 of 17 tumors. However, because of the confounding effects of serum in the medium, we studied the individual effect of 17ß-estradiol (10-8 M) when added alone under serum-free conditions. Of 20 tumors studied, 17ß-estradiol significantly enhanced cell growth in 12. There was a 67.8 ± 12.6% increase in the number of colonies formed in these 12 responding tumors. One of these 12 responding tumors was ER negative as well as PgR negative, while the rest were all ER positive. These in vitro studies demonstrate that this approach can provide valuable information on endocrine mechanisms controlling the growth of human breast cancer.

1 Supported in part by grants from the Cleveland Foundation and the Hugoton Foundation.

Received 8/ 9/85. Revised 2/20/86. Accepted 3/ 7/86.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.